Literature DB >> 10698999

Identification of Helicobacter pylori and other Helicobacter species by PCR, hybridization, and partial DNA sequencing in human liver samples from patients with primary sclerosing cholangitis or primary biliary cirrhosis.

H O Nilsson1, J Taneera, M Castedal, E Glatz, R Olsson, T Wadström.   

Abstract

Helicobacter pylori was identified in human liver tissue by PCR, hybridization, and partial DNA sequencing. Liver biopsies were obtained from patients with primary sclerosing cholangitis (n = 12), primary biliary cirrhosis (n = 12), and noncholestatic liver cirrhosis (n = 13) and (as controls) normal livers (n = 10). PCR analyses were carried out using primers for the Helicobacter genus, Helicobacter pylori (the gene encoding a species-specific 26-kDa protein and the 16S rRNA), Helicobacter bilis, Helicobacter pullorum, and Helicobacter hepaticus. Samples from patients with primary biliary cirrhosis and primary sclerosing cholangitis (11 and 9 samples, respectively) were positive by PCR with Helicobacter genus-specific primers. Of these 20 samples, 8 were positive with the 16S rRNA primer and 9 were positive with the 26-kDa protein primer of H. pylori. These nine latter samples were also positive by Southern blot hybridization for the amplified 26-kDa fragment, and four of those were verified to be H. pylori by partial 16S rDNA sequencing. None of the samples reacted with primers for H. bilis, H. pullorum, or H. hepaticus. None of the normal livers had positive results in the Helicobacter genus PCR assay, and only one patient in the noncholestatic liver cirrhosis group, a young boy who at reexamination showed histological features suggesting primary sclerosing cholangitis, had a positive result in the same assay. Helicobacter positivity was thus significantly more common in patients with cholestatic diseases (20 of 24) than in patients with noncholestatic diseases and normal controls (1 of 23) (P = <0.00001). Patients positive for Helicobacter genus had significantly higher values of alkaline phosphatases and prothrombin complex than Helicobacter-negative patients (P = 0.0001 and P = 0.0003, respectively). Among primary sclerosing cholangitis patients, Helicobacter genus PCR positivity was weakly associated with ulcerative colitis (P = 0.05). Significant differences related to blood group or HLA status were not found.

Entities:  

Mesh:

Substances:

Year:  2000        PMID: 10698999      PMCID: PMC86342     

Source DB:  PubMed          Journal:  J Clin Microbiol        ISSN: 0095-1137            Impact factor:   5.948


  32 in total

1.  Spontaneous course of symptoms in primary sclerosing cholangitis: relationships with biochemical and histological features.

Authors:  R Olsson; U Broomé; A Danielsson; I Hägerstrand; G Järnerot; L Lööf; H Prytz; B O Rydén
Journal:  Hepatogastroenterology       Date:  1999 Jan-Feb

2.  The liver in ulcerative colitis.

Authors:  A D Perrett; G Higgins; H H Johnston; G R Massarella; S C Truelove; R Wright
Journal:  Q J Med       Date:  1971-04

3.  Prevalence of primary sclerosing cholangitis in patients with ulcerative colitis.

Authors:  R Olsson; A Danielsson; G Järnerot; E Lindström; L Lööf; P Rolny; B O Rydén; C Tysk; S Wallerstedt
Journal:  Gastroenterology       Date:  1991-05       Impact factor: 22.682

4.  Effect of biliary tract procedures on duodenogastric reflux and the gastric mucosa.

Authors:  J Kellosalo; M Alavaikko; S Laitinen
Journal:  Scand J Gastroenterol       Date:  1991-12       Impact factor: 2.423

5.  Chronic active hepatitis in mice caused by Helicobacter hepaticus.

Authors:  J M Ward; M R Anver; D C Haines; R E Benveniste
Journal:  Am J Pathol       Date:  1994-10       Impact factor: 4.307

6.  Primary sclerosing cholangitis: a review of its clinical features, cholangiography, and hepatic histology.

Authors:  R W Chapman; B A Arborgh; J M Rhodes; J A Summerfield; R Dick; P J Scheuer; S Sherlock
Journal:  Gut       Date:  1980-10       Impact factor: 23.059

7.  Isolation and biochemical and molecular analyses of a species-specific protein antigen from the gastric pathogen Helicobacter pylori.

Authors:  P W O'Toole; S M Logan; M Kostrzynska; T Wadström; T J Trust
Journal:  J Bacteriol       Date:  1991-01       Impact factor: 3.490

8.  Sensitivity of Helicobacter pylori to different bile salts.

Authors:  M L Hänninen
Journal:  Eur J Clin Microbiol Infect Dis       Date:  1991-06       Impact factor: 3.267

9.  Changes in biliary lipid concentrations in bile duct obstruction: an experimental study.

Authors:  G R Xu; C J Kirk; A W Goode
Journal:  J R Soc Med       Date:  1986-09       Impact factor: 5.344

10.  Isolation of Helicobacter pylori from feces of patients with dyspepsia in the United Kingdom.

Authors:  S M Kelly; M C Pitcher; S M Farmery; G R Gibson
Journal:  Gastroenterology       Date:  1994-12       Impact factor: 22.682

View more
  72 in total

Review 1.  The role of microorganisms in biliary tract disease.

Authors:  Asa Ljungh; Torkel Wadström
Journal:  Curr Gastroenterol Rep       Date:  2002-04

Review 2.  Non-pylori Helicobacter species in humans.

Authors:  J L O'Rourke; M Grehan; A Lee
Journal:  Gut       Date:  2001-11       Impact factor: 23.059

3.  Sclerosing cholangitis in baboons (Papio spp) resembling primary sclerosing cholangitis of humans.

Authors:  A M Arenas-Gamboa; J J Bearss; G B Hubbard; B F Porter; M A Owston; E J Dick
Journal:  Vet Pathol       Date:  2011-09-20       Impact factor: 2.221

4.  Chronic Helicobacter infection of the human liver and bile are common and may trigger autoimmune disease.

Authors:  Torkel Wadström; And Asa Ljungh
Journal:  Curr Gastroenterol Rep       Date:  2002-10

5.  Infection of Helicobacter species and liver disease.

Authors:  Kazunari Murakami
Journal:  J Gastroenterol       Date:  2012-04-12       Impact factor: 7.527

Review 6.  Immunopathogenesis of primary sclerosing cholangitis.

Authors:  Joy Worthington; Sue Cullen; Roger Chapman
Journal:  Clin Rev Allergy Immunol       Date:  2005-04       Impact factor: 8.667

Review 7.  Association between Helicobacter spp. infections and hepatobiliary malignancies: a review.

Authors:  Fany Karina Segura-López; Alfredo Güitrón-Cantú; Javier Torres
Journal:  World J Gastroenterol       Date:  2015-02-07       Impact factor: 5.742

Review 8.  Etiopathogenesis of primary sclerosing cholangitis.

Authors:  Roger Chapman; Sue Cullen
Journal:  World J Gastroenterol       Date:  2008-06-07       Impact factor: 5.742

9.  Identification of Helicobacter pylori in Gallstone, Bile, and Other Hepatobiliary Tissues of Patients with Cholecystitis.

Authors:  Jin-Woo Lee; Don Haeng Lee; Jung Il Lee; Seok Jeong; Kye Sook Kwon; Hyung Gil Kim; Yong Woon Shin; Young Soo Kim; Mi Sook Choi; Si Young Song
Journal:  Gut Liver       Date:  2010-03-25       Impact factor: 4.519

Review 10.  Effects of Helicobacter infection on research: the case for eradication of Helicobacter from rodent research colonies.

Authors:  Maciej Chichlowski; Laura P Hale
Journal:  Comp Med       Date:  2009-02       Impact factor: 0.982

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.